The “E” in Cost-Effectiveness Analyses. A Case Study of Omalizumab Efficacy and Effectiveness for Cost-Effectiveness Analysis Evidence

2014 ◽  
Vol 11 (Supplement 2) ◽  
pp. S105-S111 ◽  
Author(s):  
Jonathan D. Campbell ◽  
R. Brett McQueen ◽  
Andrew Briggs
Sign in / Sign up

Export Citation Format

Share Document